Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 1,105 | 168 | 278 | 0 | 0 |
| Cost of Goods | 506 | 151 | 317 | 0 | 0 |
| Gross Profit | 599 | 17 | -39 | N/A | N/A |
| Operating Expenses | 45,977 | 36,020 | 26,434 | 22,372 | 19,244 |
| Operating Income | -44,872 | -35,852 | -26,156 | -22,372 | -19,244 |
| Other Income | -1,280 | -4,744 | -3,741 | -30,294 | 98 |
| Pre-tax Income | -46,152 | -40,596 | -29,897 | -52,666 | -19,146 |
| Income Tax | 1 | 2 | 2 | 0 | N/A |
| Net Income Continuous | -46,153 | -40,598 | -29,899 | -52,666 | -19,146 |
| Net Income | $-46,151 | $-40,598 | $-29,899 | $-52,666 | $-19,146 |
| EPS Basic Total Ops | -1,057.50 | -824.59 | -693.40 | -1,705.40 | -749.63 |
| EPS Basic Continuous Ops | -1,057.35 | -826.07 | -690.00 | -1,710.67 | -744.48 |
| EPS Diluted Total Ops | -1,057.50 | -824.59 | -693.40 | -1,705.40 | -749.63 |
| EPS Diluted Continuous Ops | -1,057.35 | -826.07 | -690.00 | -1,710.67 | -744.48 |
| EBITDA(a) | $-44,677 | $-35,731 | $-26,098 | $-22,318 | $-19,175 |